Subgroup analysis of elderly patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.11575
Abstract: 11575Background: Approximately 50% of patients diagnosed with soft tissue sarcoma (STS) are aged ≥65 years (yrs). The management of elderly STS patients (≥65yrs) is challenging and there are few pr... read more here.
Keywords: patients treated; treated within; subgroup analysis; elderly patients ... See more keywords